𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mycophenolate mofetil monotherapy for pemphigus vulgaris

✍ Scribed by R-O. Bredlich; M. Grundmann-Kollmann; S. Behrens; M. Kerscher; R.U. Peter


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
131 KB
Volume
141
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Psoriasis vulgaris treated successfully
✍ Haufs; Beissert; Grabbe; SchÜtte; Luger πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 290 KB

Mycophenolate mofetil (MMF) is a new immunosuppressive drug which non-competitively and reversibly blocks the de novo synthesis of guanine nucleotides required for DNA and RNA synthesis during T- and B-cell proliferation. This induces a selective inhibition of lymphocyte proliferation. Thus MMF is c

Use of mycophenolate mofetil in the trea
✍ J.V. Williams; J.G. Marks JR.; E.M. Billingsley πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 322 KB

## Abstract Paraneoplastic pemphigus (PNP) is a rare autoimmune blistering disease with circulating antibodies that bind the cell surface of the epidermis and other non-stratifying epithelia, and immunoprecipitate a complex of four or five proteins (250 kDa, 230 kDa, 210 kDa, 190 kDa and occasional

Mycophenolate mofetil monotherapy in liv
✍ Kyrsten D. Fairbanks; Paul J. Thuluvath πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

The long-term use of calcineurin inhibitors (CIs) is associated with significant morbidity in liver transplant recipients. Although mycophenolate mofetil (MMF) is well tolerated, two small studies reported an unacceptable rate of acute allograft rejection in liver transplant recipients receiving MMF